Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease
- PMID: 8043326
- PMCID: PMC1025439
- DOI: 10.1136/hrt.71.6.504
Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease
Similar articles
-
Hemostatic factors and the risk of myocardial infarction.N Engl J Med. 1995 Aug 10;333(6):389; author reply 389-90. N Engl J Med. 1995. PMID: 7609765 No abstract available.
-
Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina.Br Heart J. 1994 Feb;71(2):151-5. doi: 10.1136/hrt.71.2.151. Br Heart J. 1994. PMID: 8130023 Free PMC article.
-
Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study.Int J Cardiol. 2018 Dec 1;272:208-210. doi: 10.1016/j.ijcard.2018.08.029. Epub 2018 Aug 10. Int J Cardiol. 2018. PMID: 30115418 No abstract available.
-
In vitro diagnosis of fibrinolysis: present status and desired improvements.Ann N Y Acad Sci. 1992 Dec 4;667:291-304. doi: 10.1111/j.1749-6632.1992.tb51630.x. Ann N Y Acad Sci. 1992. PMID: 1309050 Review. No abstract available.
-
Predictive value for thrombotic disease of plasminogen activator inhibitor-1 plasma levels.Int J Clin Lab Res. 1993;23(2):78-82. doi: 10.1007/BF02592287. Int J Clin Lab Res. 1993. PMID: 8518417 Review.
Cited by
-
Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation.CMAJ. 1997 Sep 15;157(6):685-9. CMAJ. 1997. PMID: 9307554 Free PMC article.
-
Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction.J Thromb Thrombolysis. 2010 May;29(4):421-8. doi: 10.1007/s11239-009-0383-6. J Thromb Thrombolysis. 2010. PMID: 19662337 Clinical Trial.
-
Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease.Cerebrovasc Dis. 2015;40(3-4):157-64. doi: 10.1159/000438494. Epub 2015 Aug 8. Cerebrovasc Dis. 2015. PMID: 26279056 Free PMC article.
-
Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.Heart. 2002 Jan;87(1):48-53. doi: 10.1136/heart.87.1.48. Heart. 2002. PMID: 11751664 Free PMC article. Clinical Trial.
-
Influence of stearic acid on hemostatic risk factors in humans.Lipids. 2005 Dec;40(12):1229-35. doi: 10.1007/s11745-005-1490-1. Lipids. 2005. PMID: 16477807 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources